Flexion Therapeutics Net Profit Margin 2012-2019 | FLXN

Flexion Therapeutics net profit margin from 2012 to 2019. Net profit margin can be defined as net Income as a portion of total sales revenue.
Flexion Therapeutics Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2019-12-31 $0.07B $-0.15B -202.70%
2019-09-30 $0.06B $-0.16B -261.67%
2019-06-30 $0.05B $-0.16B -362.22%
2019-03-31 $0.03B $-0.17B -534.38%
2018-12-31 $0.02B $-0.17B -743.48%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.270B $0.073B
Flexion Therapeutics, Inc. is a specialty pharmaceutical company. It is focused on the development and commercialization of injectable pain therapies. The Company is targeting anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. It operates in the United States. The Company's product candidate, FX006, is an injectable intra-articular, meaning in the joint, sustained-release treatment for patients with moderate to severe OA pain. It is developing two additional product candidates, FX007 for post-operative pain and FX005 to treat end-stage OA patients. Flexion Therapeutics, Inc. is headquartered in Burlington, Massachusetts.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $53.155B 30.75
Takeda Pharmaceutical (TAK) Japan $46.598B 8.17
Astellas Pharma (ALPMY) Japan $27.590B 13.78
Eisai (ESALY) Japan $19.811B 36.91
UCB SA (UCBJF) Belgium $16.930B 0.00
Merck (MKGAF) Germany $13.479B 17.68
Grifols, S.A (GRFS) Spain $13.359B 16.61
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.874B 0.00
Neurocrine Biosciences (NBIX) United States $7.853B 218.18
Catalent (CTLT) United States $7.031B 28.93
Ionis Pharmaceuticals (IONS) United States $6.522B 19.77
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.721B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $5.371B 6.55
Orion OYJ (ORINY) Finland $5.269B 23.61
STADA ARZNEIMI (STDAF) Germany $4.685B 0.00
Forty Seven (FTSV) United States $4.596B 0.00
IPSEN SA ADR (IPSEY) France $4.543B 0.00
United Therapeutics (UTHR) United States $4.121B 0.00
Evotec AG (EVTCY) Germany $3.422B 55.18
Nektar Therapeutics (NKTR) United States $3.121B 0.00
Hypermarcas (HYPMY) Brazil $3.067B 9.33
FibroGen (FGEN) United States $2.886B 0.00
PTC Therapeutics (PTCT) United States $2.794B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.696B 50.04
ChemoCentryx (CCXI) United States $2.378B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.359B 9.54
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.586B 0.00
Xencor (XNCR) United States $1.581B 64.56
Ironwood Pharmaceuticals (IRWD) United States $1.561B 18.98
Sage Therapeutics (SAGE) United States $1.389B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.354B 37.03
Theravance Biopharma (TBPH) Cayman Islands $1.350B 0.00
Corcept Therapeutics (CORT) United States $1.340B 14.99
USANA Health Sciences (USNA) United States $1.191B 12.51
Karyopharm Therapeutics (KPTI) United States $1.184B 0.00
Zogenix (ZGNX) United States $1.048B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.003B 31.07
Heron Therapeutics (HRTX) United States $0.984B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.907B 12.63
Akebia Therapeutics (AKBA) United States $0.866B 0.00
Esperion Therapeutics (ESPR) United States $0.826B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.781B 0.00
Endo (ENDP) Ireland $0.696B 1.28
Aerie Pharmaceuticals (AERI) United States $0.617B 0.00
Tilray (TLRY) Canada $0.614B 0.00
ImmunoGen (IMGN) United States $0.579B 0.00
Molecular Templates (MTEM) United States $0.575B 0.00
Radius Health (RDUS) United States $0.548B 0.00
Collegium Pharmaceutical (COLL) United States $0.531B 0.00
Portola Pharmaceuticals (PTLA) United States $0.506B 0.00
Translate Bio (TBIO) United States $0.500B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.392B 16.10
Indivior (INVVY) United States $0.388B 2.30
Innate Pharma SA (IPHYF) France $0.385B 0.00
Siga Technologies (SIGA) United States $0.370B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.360B 12.00
Ardelyx (ARDX) United States $0.354B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.347B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.331B 0.00
DURECT (DRRX) United States $0.302B 0.00
Organogenesis Holdings (ORGO) United States $0.301B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.292B 0.00
Trillium Therapeutics (TRIL) Canada $0.290B 0.00
Harpoon Therapeutics (HARP) United States $0.281B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.275B 0.00
TherapeuticsMD (TXMD) United States $0.271B 0.00
Calithera Biosciences (CALA) United States $0.266B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.263B 0.00
Lannett Co Inc (LCI) United States $0.259B 4.18
Ocular Therapeutix (OCUL) United States $0.246B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.242B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.238B 0.00
Concert Pharmaceuticals (CNCE) United States $0.232B 0.00
OptiNose (OPTN) United States $0.201B 0.00
CASI Pharmaceuticals (CASI) United States $0.185B 0.00
Rafael Holdings (RFL) United States $0.175B 0.00
Recro Pharma (REPH) United States $0.165B 0.00
MEI Pharma (MEIP) United States $0.155B 0.00
PROFOUND MEDICL (PROF) Canada $0.151B 0.00
Jounce Therapeutics (JNCE) United States $0.142B 2.56
Nature's Sunshine Products (NATR) United States $0.141B 17.68
La Jolla Pharmaceutical (LJPC) United States $0.131B 0.00
Taiwan Liposome (TLC) Taiwan $0.126B 0.00
VAXART, INC (VXRT) United States $0.122B 0.00
KalVista Pharmaceuticals (KALV) United States $0.120B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.112B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.109B 0.00
Redhill Biopharma (RDHL) Israel $0.101B 0.00
CannTrust Holdings (CTST) Canada $0.090B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.084B 0.00
Hemispherx BioPharma (AIM) United States $0.083B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.083B 0.00
IMV INC (IMV) Canada $0.082B 0.00
Champions Oncology (CSBR) United States $0.081B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.074B 0.00
SCYNEXIS (SCYX) United States $0.074B 0.00
Biomerica (BMRA) United States $0.069B 0.00
CTI BioPharma (CTIC) United States $0.069B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.068B 0.00
Xeris Pharmaceuticals (XERS) United States $0.066B 0.00
Aquestive Therapeutics (AQST) United States $0.065B 0.00
Otonomy (OTIC) United States $0.058B 0.00
CV Sciences (CVSI) United States $0.056B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.055B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.054B 16.86
Nivalis Therapeutics (ALPN) United States $0.054B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.052B 0.00
Onconova Therapeutics (ONTX) United States $0.049B 0.00
Sundial Growers (SNDL) Canada $0.048B 0.00
Infinity Pharmaceuticals (INFI) United States $0.047B 0.00
PharmAthene (ALT) United States $0.047B 0.00
GTx (ONCT) United States $0.046B 0.00
Aclaris Therapeutics (ACRS) United States $0.043B 0.00
Natural Alternatives (NAII) United States $0.043B 19.63
MediWound (MDWD) Israel $0.041B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.039B 130.71
Forward Pharma (FWP) Denmark $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
PolarityTE (PTE) United States $0.036B 0.00
IsoRay (ISR) United States $0.036B 0.00
Neos Therapeutics (NEOS) United States $0.036B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.033B 0.00
Heat Biologics (HTBX) United States $0.030B 0.00
AgeX Therapeutics (AGE) United States $0.030B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.026B 0.00
Jaguar Animal Health (JAGX) United States $0.025B 0.00
Mannatechorporated (MTEX) United States $0.025B 7.79
Eyegate Pharmaceuticals (EYEG) United States $0.025B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.024B 0.00
ElectroCore (ECOR) United States $0.023B 0.00
Novan (NOVN) United States $0.022B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.022B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.021B 0.00
Cardiome Pharma (CORV) Canada $0.021B 0.00
Lipocine (LPCN) United States $0.021B 0.00
India Globalization Capital (IGC) United States $0.018B 0.00
Bio-Path Holdings (BPTH) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.013B 0.00
China SXT Pharmaceuticals (SXTC) China $0.013B 0.00
Cyanotech (CYAN) United States $0.012B 0.00
Shineco (TYHT) China $0.012B 0.00
Can-Fite Biopharma (CANF) Israel $0.011B 0.00
KemPharm (KMPH) United States $0.011B 0.00
Vical (BBI) United States $0.010B 0.00
Regulus Therapeutics (RGLS) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.008B 0.00
Midatech Pharma (MTP) United Kingdom $0.007B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.006B 0.00
HANCOCK JAFFE (HJLI) United States $0.005B 0.00
Flex Pharma (SLRX) United States $0.003B 0.00
Xenetic Biosciences (XBIO) United States $0.003B 0.00
RXi Pharmaceuticals (PHIO) United States $0.001B 0.00